| The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. DF Cella, DS Tulsky, G Gray, B Sarafian, E Linn, A Bonomi, M Silberman, ... Journal of clinical oncology 11 (3), 570-579, 1993 | 7209 | 1993 |
| The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008 D Cella, W Riley, A Stone, N Rothrock, B Reeve, S Yount, D Amtmann, ... Journal of clinical epidemiology 63 (11), 1179-1194, 2010 | 6754* | 2010 |
| Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer K Miller, M Wang, J Gralow, M Dickler, M Cobleigh, EA Perez, T Shenkier, ... New England journal of medicine 357 (26), 2666-2676, 2007 | 3854 | 2007 |
| Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non–small cell lung cancer: a randomized trial MG Kris, RB Natale, RS Herbst, TJ Lynch Jr, D Prager, CP Belani, ... Jama 290 (16), 2149-2158, 2003 | 3454 | 2003 |
| Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations RH Dworkin, DC Turk, KW Wyrwich, D Beaton, CS Cleeland, JT Farrar, ... The journal of pain 9 (2), 105-121, 2008 | 3421 | 2008 |
| Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes D Revicki, RD Hays, D Cella, J Sloan Journal of clinical epidemiology 61 (2), 102-109, 2008 | 2261 | 2008 |
| Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial BI Rini, B Escudier, P Tomczak, A Kaprin, C Szczylik, TE Hutson, ... The Lancet 378 (9807), 1931-1939, 2011 | 2198 | 2011 |
| Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system SB Yellen, DF Cella, K Webster, C Blendowski, E Kaplan Journal of pain and symptom management 13 (2), 63-74, 1997 | 2190 | 1997 |
| Pazopanib versus sunitinib in metastatic renal-cell carcinoma RJ Motzer, TE Hutson, D Cella, J Reeves, R Hawkins, J Guo, P Nathan, ... New England Journal of Medicine 369 (8), 722-731, 2013 | 2155 | 2013 |
| Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger PA Pilkonis, SW Choi, SP Reise, AM Stover, WT Riley, D Cella, ... Assessment 18 (3), 263-283, 2011 | 2051 | 2011 |
| Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy—Spiritual Well-being Scale (FACIT-Sp) AH Peterman, G Fitchett, MJ Brady, L Hernandez, D Cella Annals of behavioral medicine 24 (1), 49-58, 2002 | 2035 | 2002 |
| Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. MJ Brady, DF Cella, F Mo, AE Bonomi, DS Tulsky, SR Lloyd, S Deasy, ... Journal of clinical oncology 15 (3), 974-986, 1997 | 1913 | 1997 |
| Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition GA Curt, W Breitbart, D Cella, JE Groopman, SJ Horning, LM Itri, ... The oncologist 5 (5), 353-360, 2000 | 1793 | 2000 |
| The F unctional A ssessment of C hronic I llness T herapy (FACIT) Measurement System: properties, applications, and interpretation K Webster, D Cella, K Yost Health and quality of life outcomes 1, 1-7, 2003 | 1766 | 2003 |
| Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items RD Hays, JB Bjorner, DA Revicki, KL Spritzer, D Cella Quality of life Research 18, 873-880, 2009 | 1749 | 2009 |
| Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS) BB Reeve, RD Hays, JB Bjorner, KF Cook, PK Crane, JA Teresi, ... Medical care 45 (5), S22-S31, 2007 | 1630 | 2007 |
| Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial S Tyring, A Gottlieb, K Papp, K Gordon, C Leonardi, A Wang, D Lalla, ... The Lancet 367 (9504), 29-35, 2006 | 1327 | 2006 |
| A case for including spirituality in quality of life measurement in oncology MJ Brady, AH Peterman, G Fitchett, M Mo, D Cella Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 1999 | 1297 | 1999 |
| Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo … TJ Littlewood, E Bajetta, JWR Nortier, E Vercammen, B Rapoport, ... Journal of clinical oncology 19 (11), 2865-2874, 2001 | 1285 | 2001 |
| Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. NJ Vogelzang, W Breitbart, D Cella, GA Curt, JE Groopman, SJ Horning, ... Seminars in hematology 34 (3 Suppl 2), 4-12, 1997 | 1231 | 1997 |
